Clinical imipenem non-susceptible Klebsiella pneumoniae isolates from China: Epidemiology, molecular characterization and in vitro activity of imipenem/relebactam
Objective: To describe the epidemiological and molecular characterization and in vitro activity of imipenem/relebactam against imipenem non-susceptible (IPMNS) Klebsiella pneumoniae isolates in China. Methods: K. pneumoniae isolates were collected from 16 sites in 5 regions across China during 2019....
Saved in:
| Main Authors: | Peiyao Jia, Pengcheng Li, Wei Yu, Xiaobing Chu, Hui Zhang, Jingjia Zhang, Wei Kang, Ge Zhang, Qian Zhang, Shiyu Chen, Yingchun Xu, Qiwen Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Journal of Global Antimicrobial Resistance |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716525001146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis
by: Emanuele Palomba, et al.
Published: (2025-04-01) -
AmpC induction by imipenem in Pseudomonas aeruginosa occurs in the absence of OprD and impacts imipenem/relebactam susceptibility
by: Shawn Freed, Jr, et al.
Published: (2024-11-01) -
Restoring Control: Real-World Success with Imipenem–Relebactam in Critical MDR Infections—A Multicenter Observational Study
by: Andrea Marino, et al.
Published: (2025-07-01) -
In vitro activity of imipenem/relebactam and comparators against Enterobacterales isolates collected in Brazilian hospitals according to results from the Study for Monitoring Antimicrobial Resistance Trends, 2020–2021
by: Amanda Azevedo Bittencourt, et al.
Published: (2025-07-01) -
In Vitro Susceptibility to Imipenem/Relebactam and Comparators in a Multicentre Collection of <i>Mycobacterium abscessus</i> Complex Isolates
by: Alejandro Seoane-Estévez, et al.
Published: (2025-07-01)